Patents Assigned to REV PHARMA CORP
  • Patent number: 10596205
    Abstract: Dental, vaginal and anal cream composed of exclusively natural active principles containing glycerides and Vitamin A and D, easily retained and preserved when in contact with the inflamed mucosa due to its adhesive mucosal base.
    Type: Grant
    Filed: December 5, 2018
    Date of Patent: March 24, 2020
    Assignee: REV PHARMA Corp.
    Inventor: Efrain Ramon Vasquez
  • Patent number: 10426803
    Abstract: A composition and method for treating Epidermolisis bullosa (EB), comprising: applying to skin or mucosal surfaces of a patient in need of treatment for EB a dressing gauze or bandage without prior cleaning of said skin or mucosal surfaces, wherein distributed on said dressing is an effective amount of a composition containing beeswax; an oleaginous base, vitamins and a pharmaceutically acceptable excipient; then removing said dressing at least twice per day without damaging the patient's skin or mucosal surfaces due to removal of the dressing.
    Type: Grant
    Filed: June 18, 2018
    Date of Patent: October 1, 2019
    Assignee: REV PHARMA CORP
    Inventor: Efrain Ramon Vasquez
  • Publication number: 20190105357
    Abstract: Dental, vaginal and anal cream composed of exclusively natural active principles containing glycerides and Vitamin A and D, easily retained and preserved when in contact with the inflamed mucosa due to its adhesive mucosal base.
    Type: Application
    Filed: December 5, 2018
    Publication date: April 11, 2019
    Applicant: REV PHARMA Corp.
    Inventor: Efrain Ramon VASQUEZ
  • Publication number: 20180296611
    Abstract: A composition and method for treating Epidermolisis bullosa (EB), comprising: applying to skin or mucosal surfaces of a patient in need of treatment for EB a dressing gauze or bandage without prior cleaning of said skin or mucosal surfaces, wherein distributed on said dressing is an effective amount of a composition containing beeswax; an oleaginous base, vitamins and a pharmaceutically acceptable excipient; then removing said dressing at least twice per day without damaging the patient's skin or mucosal surfaces due to removal of the dressing.
    Type: Application
    Filed: June 18, 2018
    Publication date: October 18, 2018
    Applicant: REV PHARMA Corp.
    Inventor: Efrain Ramon VASQUEZ
  • Patent number: 10016466
    Abstract: A composition and method for treating Epidermolisis bullosa (EB), comprising: applying to skin or mucosal surfaces of a patient in need of treatment for EB a dressing gauze or bandage without prior cleaning of said skin or mucosal surfaces, wherein distributed on said dressing is an effective amount of a composition containing beeswax; an oleaginous base, vitamins and a pharmaceutically acceptable excipient; then removing said dressing at least twice per day without damaging the patient's skin or mucosal surfaces due to removal of the dressing.
    Type: Grant
    Filed: November 13, 2015
    Date of Patent: July 10, 2018
    Assignee: REV PHARMA CORP
    Inventor: Ramon Efrain Vasquez